DBVT

DBVT

USD

DBV Technologies S.A. American Depositary Shares

$8.720-0.250 (-2.787%)

Real-time Price

Healthcare
Biotechnology
France

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$8.970

High

$9.046

Low

$8.720

Volume

0.01M

Company Fundamentals

Market Cap

252.2M

Industry

Biotechnology

Country

France

Trading Stats

Avg Volume

0.44M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.441Current $8.720High $12.78

Related News

GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI Congress 2025

Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company, today announced upcoming participation in the

View more
DBV Technologies to Participate in Upcoming EAACI Congress 2025
GlobeNewswire

DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

Châtillon, France, June 11, 2025 DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (TRQX:DBVp), a clinical-stage

View more
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025

Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025 (Article 223-16 of the General Regulations of

View more
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
GlobeNewswire

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company (the

View more
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Analyst Upgrades

JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $21

JMP Securities analyst Jonathan Wolleben maintains DBV Technologies with a Market Outperform and raises the price target from $15 to $21.

View more
JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $21